Nurse-led cardiovascular disease risk management intervention for patients with gout

European Journal of Cardiovascular Nursing

Volumn 10, Issue 2, 2011, Pages 94-100

  McLachlan, Andy ^a   Kerr, Andrew ^a,b   Lee, Mildred ^b   Dalbeth, Nicola ^a,b  

^a MIDDLEMORE HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cardiovascular risk; Decision support; Gout; Nursing

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; DIASTOLIC BLOOD PRESSURE; FEMALE; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; NURSING CARE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK MANAGEMENT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GOUT; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; NURSING ASSESSMENT; PILOT PROJECTS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955969546     PISSN: 14745151     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcnurse.2010.05.001     Document Type: Article

References (40)

1. Choi H.K., Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007, 116(8):894-900.
2. Gow P. Gout and its management. New Zealand Family Practice 2005, 32(4).
3. Edwards N.L. The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleveland Clinic Journal of Medicine 2008, 75(Suppl 5):S13-S16.
4. Krishnan E. Long-term cardiovascular mortality among middle-aged men with gout. Archives of Internal Medicine 2008, 168(10). For the MRFIT Research Group.
5. Niskanen L.K., et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Archives of Internal Medicine 2004, 164(14):1546-1551.
6. Colvine K., et al. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support. The New Zealand Medical Journal 2008, 121(1285):73-81.
7. Dawood N., et al. Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. Archives of Internal Medicine 2008, 168(18):1961-1967.
8. Wald N.J., Law M.R. A strategy to reduce CVD by more than 80%. British Medical Journal 2003, 326(1419).
9. Chobanian A.V., et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289:2560-2572. For the National High Blood Pressure Education Program Coordinating Committee.
10. Elley C.R., Kerse N., Arroll B., Robinson E. Effectiveness of counselling patients on physical activity in general practice: cluster randomised controlled trial. British Medical Journal 2003, 326:793.
11. Jackson R., et al. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005, 365(9457):434-441.
12. Kotseva K., et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009, 373(9667):929-940.
13. D'Agostino R.B., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117(6):743-753.
14. The assessment and management of CVD risk 2003, New Zealand Guideline Group, Wellington. New Zealand.
15. Janssens H., et al. Gout, just a nasty event or a cardiovascular signal? A study from primary care. Family Practice 2003, 20(4):413-416.
16. Winnard D., et al. Debunking the myths to provide 21st century management of gout. The New Zealand Medical Journal 2008, 121(1274).
17. Page T., Lockwood C., Conroy-Hiller T. Effectiveness of nurse-led cardiac clinics in adult patients with a diagnosis of coronary heart disease. International Journal of Evidence-Based Healthcare 2005, 13(1):2-26.
18. European action on secondary prevention by intervention to reduce events. Lancet 2001, 357(9261):995-1001. Euroaspire Group.
19. McPherson C.P., Swenson K.K., Pine D.A., Leimer L. A nurse based pilot program to reduce cardiovascular risk factors in a primary care setting. The American Journal of Managed Care 2002, 8:543-555.
20. Murchie P., et al. Running nurse led secondary prevention clinics for coronary heart disease in primary care. The British Journal of General Practice 2005, 55:522-528.
21. Coleman M.T., Newton K.S. Supporting self management in patients with chronic illness. American Family Physician 2005, 72(8):1503-1510.
22. Singh, V.N., Cardiac Rehabilitation. Medscape. 2008. DOI: http://emedicine.medscape.com/article/319683-overview.
23. Wood, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008, 371:1999-2012.
24. Counties Manukau District Health Board, Population demography and needs. 2009 [cited 12/05/2009]; available from: http://www.cmdhb.org.nz/About_CMDHB/Overview/population-profile.htm.
25. Kerr A., et al. The burden of modifiable cardiovascular risk factors in the coronary care unit by age, ethnicity, and socioeconomic status - PREDICT CVD-9. The New Zealand Medical Journal 2008, 121(1285).
26. King A. The New Zealand health strategy 2000, Ministry of Health, Wellington, NZ.
27. Rea H., et al. Chronic care management evolves towards integrated care in Counties Manukau, New Zealand. The New Zealand Medical Journal 2007, 120(1252).
28. Horsburgh M., Goodyear-Smith F., Yallop J. Nursing initiatives in primary care: an approach to risk reduction for cardiovascular disease and diabetes. New Zealand Family Practice 2008, 35:176-182.
29. Sinclair G., Kerr A. The Bold Promise Project; a system change in primary care to support CVD risk screening. The New Zealand Medical Journal 2006, 119(1245).
30. Kerr A.J., et al. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?. Heart 2009, 95:125-129.
31. Bannink L., et al. Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1). The New Zealand Medical Journal 2006, 119(1245):2313.
32. Riddell T., et al. Assessing Māori/non-Māori differences in cardiovascular disease risk and risk management in routine primary care practice using web-based clinical decision support: (PREDICT CVD-2). The New Zealand Medical Journal 2007, 120(1250).
33. Khunti K., et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart 2007, 93(11):1398-1405.
34. Wagner E.H., et al. Improving chronic illness care. Translating evidence into action. Health Affairs 2000, 20(6):64-78.
35. Lawton B., et al. Exercise on prescription for women aged 40-74 recruited through primary care: Two year randomised controlled trial. British Medical Journal 2008, 337:2509.
36. New Zealand Smoking Cessation Guidelines 2007, Ministry of Health, Ministry of Health, Wellington.
37. McLoughney C.R., Khan A.S.A., Ahmed A.B. Effectiveness of a specialist nurse-led intervention clinic in the management of cardiovascular risk factors in diabetes. European Diabetes Nursing 2007, 4(3):100-105.
38. Campbell N.C., et al. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart 1998, 80(5):447-452.
39. Jolly L. The role of the specialist nurse. Heart 2002, 88(90002). 33ii-35.
40. Campbell N.C. Secondary prevention clinics: improving quality of life and outcome. Heart 2004, 90(suppl4). iv29-32.